Abstract
The way each country counts and reports the incident cases of SARS-CoV-2 infections is strongly affected by the “weekend effect”. During the weekend, fewer tests are carried out and there is a delay in the registration of cases. This introduces an “administrative noise” that can strongly disturb the calculation of trend estimators such as the effective reproduction number R(t). In this work we propose a procedure to correct the incidence curve and obtain a better fit between the number of infected and the one expected using the renewal equation. The classic way to deal with the administrative noise is to invoke its weekly period and therefore to filter the incidence curve by a seven days sliding mean. Yet this has three drawbacks: the first one is a loss of resolution. The second one is that a 7-day mean filter hinders the estimate of the effective reproduction number R(t) in the last three days before present. The third drawback of a mean filter is that it implicitly assumes the administrative noise to be additive and time invariant. The present study supports the idea that the administrative is better dealt with as being both periodic and multiplicative. The simple method that derives from these assumptions amount to multiplying the number of infected by a correcting factor which depends on the day of the week. This correcting factor is estimated from the incidence curve itself. The validity of the method is demonstrated by its positive impact on the accuracy of an the estimates of R(t). To exemplify the advantages of the multiplicative periodic correction, we apply it to Sweden, Germany, France and Spain. We observe that the estimated administrative noise is country dependent, and that the proposed strategy manages to reduce it noise considerably. An implementation of this technique is available at www.ipol.im/ern, where it can be tested on the daily incidence curves of an extensive list of states and geographic areas provided by the European Centre for Disease Prevention and Control.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
no external funding was received
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
No approval necessary; only public and anonymous data were used
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Abbreviations
- EpiEstim
- Software to compute the effective reproduction number proposed by Cori et al. in the paper: A new framework and software to estimate time-varying reproduction numbers during epidemics published in the American Journal of Epidemiology.
- R(t)
- Effective Reproduction Number. To differentiate between the continuous and discrete cases, we use the notation R(t) in the continuous case and Rt in the discrete case.
- i(t)
- incidence curve, the number of daily tested positive registered. To differentiate between the continuous and discrete cases, we use the notation i(t) in the continuous case and it in the discrete case.
- Φ
- serial interval.
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.